Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

PGNX $8.46 +0.00%
BCRX $15.34 +0.00%
MGNX $37.16 +0.00%
MACK $10.20 +0.00%
MNTA $21.75 +0.00%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

PGNX $8.46 +0.00%
BCRX $15.34 +0.00%
MGNX $37.16 +0.00%
MACK $10.20 +0.00%
MNTA $21.75 +0.00%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next > | Last >>

FDA Approves Balloon For Weight Loss

(UPI) July 29, 2015 - An inflatable balloon device has been approved by the Food and Drug Administration to help obese patients lose weight without surgery.
read article 



Sanofi's Combination Diabetes Drug Hits Goal In Late-Stage Trial

(Reuters) July 29, 2015 - Sanofi said on Wednesday a first late-stage Phase III study of its LixiLan diabetes drug had met its main target, while another would be completed at the end of the third quarter.
read article 



Pfizer Quits Over-the-Counter Lipitor Program After Trial Fails

(Bloomberg) July 28, 2015 - Pfizer Inc. won’t bring an over-the-counter version of its cholesterol pill Lipitor to the U.S. market, after a trial found that patients couldn’t take the drug correctly without a doctor’s help.
read article 



'Jaw-dropping': Medicare Deaths, Hospitalizations AND Costs Reduced

(USA Today) July 28, 2015 - The U.S. health care system has scored a medical hat trick, reducing deaths, hospitalizations and costs, a new study shows.
read article 



Pricey Drugs Largely To Blame For Uptick In National Health Expenditures

(Forbes) July 28, 2015 - New CMS projections of national health expenditures show a rise in spending growth over the next decade. Pricey new drugs for diseases like hepatitis C and cancer are largely responsible for the trend.
read article 



Reps. Dingell, Murphy Announce Bipartisan Cancer Prevention Caucus

(Congresswoman Debbie Dingell) July 28, 2015 - Today, Congresswoman Debbie Dingell (MI-12) and Congressman Tim Murphy (PA-18) announced the formation of the bipartisan Congressional Cancer Prevention Caucus.
read press release 



Skin Doctors Urge Under-18 Ban On Tanning Beds

(Yahoo! News/Associated Press) July 29, 2015 - Dermatologists who treat skin cancer patients urged state lawmakers on Tuesday to approve a bill that would bar anyone under age 18 from using tanning beds, but salon owners accused critics of overstating the risks.
read article 



Opinion: Transparency: The Best Medicine For 340B Drug-Pricing Program

(Watchdog.org/Bluegrass Institute) July 27, 2015 - If ever a well-intentioned government program was trusted too much and verified too little, it’s the 340B Drug Pricing plan created by Congress in 1992 to help indigent and uninsured patients acquire costly prescription medicines.
read article 



Galena Biopharma Launches Zuplenz(R) (ondansetron) Oral Soluble Film

(Galena Biopharma) July 29, 2015 - Galena Biopharma, Inc. today announced the product launch for Zuplenz® (ondansetron) Oral Soluble Film in the United States.
read corporate press release 



R-Biopharm and Apogenix Will Develop Companion Diagnostic Tests for Apogenix’ Immuno-Oncology Candidate APG101

(R-Biopharm) July 28, 2015 - R-Biopharm AG, a global provider of innovative clinical diagnostics, announced today that it has entered into a research and development cooperation with Apogenix GmbH, a next generation immuno-oncology company, for the development of companion diagnostic tests (CDx) for Apogenix’ lead product APG101, a novel targeted anti-cancer therapy.
read corporate press release 



Gores Group Said to Mull Sale of Immunotherapy Business Therakos

(Bloomberg) July 28, 2015 - U.S. buyout firm Gores Group is weighing a sale of immunotherapy company Therakos amid a boom in health care deals, according to people with knowledge of the matter.
read article 



Billionaire Soon-Shiong's NantKwest Surges 39% In First Day Of Trading

(Los Angeles Times) July 29, 2015 - Patrick Soon-Shiong — pharmaceutical entrepreneur, part owner of the Lakers and the wealthiest man in Los Angeles — just got a little richer.
read article (free registration required) 



Refocusing Cancer Drug Approval on Patients

(Huffington Post/The Blog) July 28, 2015 - As therapies are increasingly designed to more precisely target cancer, the old paradigm has become obsolete.
read article 



Atezolizumab Could Spur Bladder Cancer Treatment Innovation

(European Pharmaceutical Review) July 28, 2015 - Roche’s atezolizumab is poised to become a major bladder cancer therapy in the race for US Food & Drug Administration (FDA) approval, following its promising performance in recent Phase II trials, says an analyst with research and consulting firm GlobalData.
read article 



'Clash of Titans' About Novel Radiotherapy for Breast Cancer

(Medscape Medical News) July 28, 2015 - A war of words appears to be escalating between two camps of radiation oncologists over the results of a major clinical trial of early-stage breast cancer. It has been called a "clash of titans" by some observers.
read article (free registration required) 



Tools for Taking the Measure of Cancer Drugs

(Managed Care Magazine) July 2015 – How much is a cancer medication really worth? The answer can depend upon whom you ask. But now, there is a new pair of tools to help sort out this vexing and contentious issue.
read article 



Cancer Healthcare Disparities Exist in the LGBTQ Community, Say Moffitt Cancer Center Researchers

(Moffitt) July 23, 2015 - More research, inclusive insurance and governmental policies are needed to improve cancer healthcare for the Lesbian, Gay, Bisexual, Transgender, Queer community.
read press release 



A Dangerous Liaison

(Ludwig-Maximilians-Universität [Munich, Germany]) July 28, 2015 - LMU researchers have elucidated at the molecular level how an otherwise innocuous inherited mutation that is quite common in European populations interacts with a spontaneous somatic mutation to promote the development of Ewing’s sarcoma.
read article 



New Treatment Options For a Fatal Leukemia

(University of Zurich) July 27, 2015 - A pediatric oncologist from the University of Zurich has succeeded in decoding a rare but always fatal subtype of this leukemia and in obtaining pointers for new therapeutic possibilities.
read press release 



Penn Scientists Find That Flow Means "Go" for Proper Lymph System Development

(Penn Medicine) July 27, 2015 - Findings in mice hint at new approaches for treating lymphedema, other chronic lymphatic disorders.
read press release 



New Tool Uses 'Drug Spillover' To Match Cancer Patients With Treatments

(UCCC/Colorado Cancer Blogs) July 28, 2015 - A recent article in the journal Bioinformatics from researchers at the University of Colorado Cancer Center describes a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best “kinase inhibitor” to silence these dangerous genetic causes of disease.
read article 



UNM Cancer Center Scientists Discover that an Anti-Inflammatory Drug Acts Against Ovarian Cancer

(UNM Cancer Center) July 28, 2015 - A team of scientists at the University of New Mexico Cancer Center published a research paper showing that a non-steroidal anti-inflammatory drug (NSAID) called ketorolac helped women with ovarian cancer to survive longer.
read press release 



UCLA Scientists Discover Breakthrough Experimental Therapy To Treat Colon Cancer And Chronic Inflammatory Bowel Disease

(UCLA Jonsson CCC) July 23, 2015 - UCLA scientists have discovered a groundbreaking experimental therapy that has the ability to suppress the development of ulcerative colitis (UC), a disease which causes inflammation in the digestive tract and colon cancer.
read press release 



Not Resecting Ideal Candidates Ups Mortality in Liver Cancer

(Physician’s Briefing/HealthDay News) July 28, 2015 - For patients with hepatocellular carcinoma (HCC), not resecting ideal candidates for resection is associated with increased mortality, according to a study published in the Aug. 1 issue of Hepatology.
read article 



Lung Cancer Risk Linked To 'Slow-Ageing' DNA Hallmark

(Yahoo! News/Press Association) July 29, 2015 - A genetic hallmark of people who age slowly has been linked to an increased risk of lung cancer.
read article